Company / Operating Income per Share
Cytokinetics Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$5097.77
FY2025
5-year range
-$5097.77 / -$2.20
FY2021-FY2025
Trend
-96520.8%
vs FY2024
Sector context
#201 of 201
Health Care
What the data says
Operating Income per Share changed -96521% YoY in FY2025, a notable deviation from the 9-year average annual change of -10802%.
Based on SEC 10-K filings.
-5097.77 in FY2025.
Declined from $-5.23 to $-5097.77 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 201This company -$5097.77 Sector average -$28.56
▼
-17751.1% below sector average
Key checks
Key Insights
- Cytokinetics's operating income per share has declined for 5 consecutive years.
- In FY2025, operating income per share decreased 96520.8% year-over-year.
- Ranks #201 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5097.77 | -96520.8% |
| FY2024 | -$5.28 | -0.8% |
| FY2023 | -$5.23 | -36.9% |
| FY2022 | -$3.82 | -74.0% |
| FY2021 | -$2.20 | -66.1% |
| FY2020 | -$1.32 | +20.8% |
| FY2019 | -$1.67 | -2.8% |
| FY2018 | -$1.62 | +22.7% |
| FY2017 | -$2.10 | -557.1% |
| FY2016 | $0.46 | +148.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026